New GSK Regional Head to Drive Innovation and Access Across the Region

Egypt is rapidly emerging as a vital hub in the evolving global healthcare landscape. With its significant population, skilled talent, and a government deeply committed to health, the country presents a unique opportunity for accelerated innovation and improved patient outcomes. GSK recognizes this potential, reinforcing its long-term commitment to Egypt by prioritizing innovation, vaccines, and access to medicines.

We recently sat down with Dr. Mohamed El-Dababy, GSK's Regional President for Africa, the Middle East, Turkey, and Eastern Europe. In this exclusive interview, Dr. El-Dababy shares his strategic vision for the next phase, detailing Egypt's crucial role within GSK's regional strategy. He also discusses how the company plans to capitalize on growth opportunities, enhance access to groundbreaking vaccines and medicines, champion scientific research, and cultivate high-performing teams to deliver lasting health benefits for patients."

1. Vision:  Congratulations on your appointment as Regional Head for Africa, the Middle East, and countries of Eastern Europe. As you step into this pivotal role, what are your immediate priorities and your overarching vision?

Answer: Thank you, it is a privilege to take on this role.  My immediate priority is to connect deeply with our teams across the region. To better understand the unique dynamics and opportunities in each market.